The Pharma Data

DECEMBER 15, 2020

The Phase III trial evaluated the use of the diabetes vaccine Diamyd ® , an antigen-specific immunotherapy based on the auto-antigen GAD (glutamic acid decarboxylase), to induce immunological tolerance and stop the autoimmune destruction of insulin producing cells. People with type 1 diabetes cannot produce insulin.

Development 40

Development Insulin Drugs Clinical Trials 40

pharmaphorum

MARCH 7, 2022

The World Health Organization (WHO) announced the opening of a global biomanufacturing hub located in South Korea to provide training to low- and middle-income countries seeking to produce vaccines and other biologics, such as insulin and monoclonal antibodies. .

Vaccination 98

Vaccination Vaccine Manufacturing Production 98

The Pharma Data

SEPTEMBER 11, 2021

Results from EMPEROR-Preserved were presented at the European Society of Cardiology Congress 2021 on August 27 and published in The New England Journal of Medicine. No currently approved treatments have been clinically proven to significantly improve outcomes specifically for people with HFpEF. are on a low salt diet. drowsiness.

Medicine 52

Medicine Insulin FDA Approval Trials 52

Delveinsight

AUGUST 20, 2020

Generating insulin-producing pancreatic beta cells from stem cells to substitute those damaged by the immune system is a promising approach for diabetes treatment. Nipocalimab is in clinical development in myasthenia gravis , warm autoimmune hemolytic anemia (wAIHA), and hemolytic disease of the fetus and newborn indications.

Gene Therapy 52

Gene Therapy Research Gene Antibody 52

Delveinsight

AUGUST 25, 2021

The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutical drugs for usage as medications that are administered (or self-administered) to patients in order to cure, vaccinate, or relieve symptoms. Roche Pharmaceuticals Clinical Pipeline. It generated a whopping revenue of USD 82.5

Vaccination 98

Vaccination Vaccine Sales Drugs 98

Delveinsight

JULY 21, 2021

Currently, the Rheumatoid Arthritis treatment options include Medicine (for the long term to relieve symptoms and slow the progress of the condition, supportive treatments (such as physiotherapy, podiatry, and occupational therapy). Surgery is also considered to correct the joint problems that had developed over a period of time.

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

Drug Discovery World

JULY 13, 2023

Following the death of a cancer patient after they were given an unlicensed drug, Diana Spencer unpacks the practice of prescribing unlicensed and off-label medicines. In a statement, the company at fault claimed the problem was caused by an issue at its medicines manufacturing unit.

Drugs 94

Drugs Medicine Regulation Licensing 94

The Pharma Data

DECEMBER 13, 2020

7.1%) levels were well controlled, and in this context, significant placebo-adjusted decreases were observed in both glycemic parameters along with improvements in commonly used fasting indexes of insulin sensitivity (HOMA-IR and QUICKI scores). Harrison, MD, Director, Summit Clinical Research. .

Trials 52

Trials In-Vitro Insulin Protein 52

The Pharma Data

JULY 8, 2021

“We look forward to presenting the EMPEROR-Preserved results at ESC 2021, which should offer a significant breakthrough in cardiovascular medicine and a new hope for people with HFpEF, which is an increasingly prevalent public health issue. vice president, Product Development, Lilly. Wh a t is JARDIANCE?

Trials 52

Trials Doctors Doctor Medicine 52

XTalks

AUGUST 2, 2023

With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions. In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

JUNE 28, 2021

.” Tirzepatide is a novel investigational once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that integrates the actions of the GIP and GLP-1 incretins into a single molecule, representing a new class of medicines being studied for the treatment of type 2 diabetes. mg, 5 mg and 7.5

Clinical Trials 40

Clinical Trials Clinical Trials Hormones Trials 40

The Pharma Data

DECEMBER 15, 2020

Scientists at Charité, University Medicine Berlin , have been able to use daratumumab to successfully treat two female patients who have systemic lupus erythematosus. Patients treated with avacopan achieved both primary endpoints of clinical remission at 26 and 52 weeks. Monoclonal Antibodies. Oral, Small Molecules.

Clinical Trials 52

Clinical Trials Clinical Trials Antibody Trials 52

The Pharma Data

APRIL 4, 2023

The accelerated approval designation granted today is part of the FDA’s Accelerated Approval Program, which allows earlier approval of a medicine based on a surrogate endpoint if the medicine fills an unmet medical need for a serious condition. Initiate treatment with insulin as clinically indicated.

FDA Approval 40

FDA Approval Containment Hormones Dermatology 40

The Pharma Data

JULY 23, 2021

The goal of the company’s cancer research is to deliver medicines that offer each patient a better, healthier life and to make cure a possibility. To date, the Opdivo clinical development program has treated more than 35,000 patients.

Hormones 52

Hormones Trials Genome Genomics 52

The Pharma Data

MARCH 11, 2021

The goal of the company’s cancer research is to deliver medicines that offer each patient a better, healthier life and to make cure a possibility. To date, the Opdivo clinical development program has treated more than 35,000 patients.

Trials 52

Trials Hormones Genome Genomics 52

The Pharma Data

JUNE 28, 2021

” Tirzepatide is a novel investigational once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that integrates the actions of both incretins into a single molecule, representing a new class of medicines being studied for the treatment of type 2 diabetes. Source link: [link].

Insulin 52

Insulin Clinical Trials Clinical Trials Hormones 52

The Pharma Data

MARCH 5, 2021

Tirzepatide is a novel investigational once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that integrates the actions of both incretins into a single molecule, representing a new class of medicines being studied for the treatment of type 2 diabetes. Source link:[link].

Clinical Trials 52

Clinical Trials Clinical Trials Trials Hormones 52